Nurix Therapeutics (NRIX) EV to EBITDA (2020 - 2026)
Powered by 
Analysis
Nurix Therapeutics (NRIX) EV to EBITDA (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.42 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -14.84 |
| Feb 28, 2026 | -12.01 |
| Nov 30, 2025 | -14.53 |
| Aug 31, 2025 | -3.16 |
| May 31, 2025 | -6.76 |
| Feb 28, 2025 | -9.99 |
| Nov 30, 2024 | -16.52 |
| Aug 31, 2024 | -22.75 |
| May 31, 2024 | -11.75 |
| Feb 29, 2024 | -8.02 |
| Nov 30, 2023 | -0.33 |
| Aug 31, 2023 | -3.83 |
| May 31, 2023 | -7.50 |
| Feb 28, 2023 | -3.96 |
| Nov 30, 2022 | -5.65 |
| Aug 31, 2022 | -8.50 |
| May 31, 2022 | -3.44 |
| Feb 28, 2022 | -10.84 |
| Nov 30, 2021 | -26.12 |
| Aug 31, 2021 | -37.60 |